MD502G2 - Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin - Google Patents

Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin

Info

Publication number
MD502G2
MD502G2 MD95-0111A MD950111A MD502G2 MD 502 G2 MD502 G2 MD 502G2 MD 950111 A MD950111 A MD 950111A MD 502 G2 MD502 G2 MD 502G2
Authority
MD
Moldova
Prior art keywords
derivatives
obtainitg
adenozine
farmaceutical
compositions
Prior art date
Application number
MD95-0111A
Other languages
English (en)
Romanian (ro)
Russian (ru)
Other versions
MD502F1 (en
Inventor
Nicole Bru-Magniez
Timur Gungor
Jean-Marie Teulon
Original Assignee
Laboratoires Upsa, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Upsa, S.A. filed Critical Laboratoires Upsa, S.A.
Publication of MD502F1 publication Critical patent/MD502F1/xx
Publication of MD502G2 publication Critical patent/MD502G2/ro

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
MD95-0111A 1992-01-08 1994-12-30 Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin MD502G2 (ro)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9200138A FR2685918B1 (fr) 1992-01-08 1992-01-08 Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.

Publications (2)

Publication Number Publication Date
MD502F1 MD502F1 (en) 1996-03-29
MD502G2 true MD502G2 (ro) 1996-11-30

Family

ID=9425478

Family Applications (1)

Application Number Title Priority Date Filing Date
MD95-0111A MD502G2 (ro) 1992-01-08 1994-12-30 Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin

Country Status (25)

Country Link
US (2) US5229505A (fr)
EP (1) EP0623138B1 (fr)
JP (1) JP3224542B2 (fr)
KR (1) KR100232672B1 (fr)
AT (1) ATE153342T1 (fr)
AU (1) AU661894B2 (fr)
CA (1) CA2127472C (fr)
CZ (1) CZ289047B6 (fr)
DE (1) DE69219901T2 (fr)
DK (1) DK0623138T3 (fr)
EE (1) EE03087B1 (fr)
ES (1) ES2105285T3 (fr)
FI (1) FI106205B (fr)
FR (1) FR2685918B1 (fr)
GE (1) GEP19981357B (fr)
GR (1) GR3024386T3 (fr)
HU (1) HU221304B1 (fr)
LV (1) LV11899B (fr)
MD (1) MD502G2 (fr)
NZ (1) NZ246904A (fr)
RU (1) RU2129560C1 (fr)
SK (1) SK282205B6 (fr)
TW (1) TW254945B (fr)
UA (1) UA44221C2 (fr)
WO (1) WO1993014102A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.
FR2714907B1 (fr) * 1994-01-07 1996-03-29 Union Pharma Scient Appl Nouveaux dérivés de l'Adénosine, leurs procédés de préparation, compositions pharmaceutiques les contenant.
WO1995018817A1 (fr) * 1994-01-07 1995-07-13 Laboratoires Upsa Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant
TW528755B (en) 1996-12-24 2003-04-21 Glaxo Group Ltd 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
FR2772271B1 (fr) * 1997-12-11 2000-09-01 Union Pharma Scient Appl Nouvelle association pharmaceutique a activite analgesique
YU44900A (sh) 1998-01-31 2003-01-31 Glaxo Group Limited Derivati 2-(purin-9-il)tetrahidrofuran-3,4-diola
CN1313861A (zh) 1998-06-23 2001-09-19 葛兰素集团有限公司 2－(嘌呤－9－基)－四氢呋喃－3,4－二醇衍生物
JP2002173427A (ja) * 1998-09-01 2002-06-21 Yamasa Shoyu Co Ltd 眼疾患治療用医薬組成物
DE19924818A1 (de) 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
EP2308522A3 (fr) * 1999-11-17 2012-02-29 Boston Scientific Limited Dispositifs microfabriques pour transport de molécules dans un fluide porteur
WO2002020539A1 (fr) * 2000-09-08 2002-03-14 Toa Eiyo Ltd. Derives d'adenosine et leur utilisation
EP1352910A1 (fr) * 2002-04-10 2003-10-15 Grünenthal GmbH Nouveaux derives d'analogues de nitrobenzylthioinosine
PE20060272A1 (es) 2004-05-24 2006-05-22 Glaxo Group Ltd (2r,3r,4s,5r,2'r,3'r,4's,5's)-2,2'-{trans-1,4-ciclohexanodiilbis-[imino(2-{[2-(1-metil-1h-imidazol-4-il)etil]amino}-9h-purin-6,9-diil)]}bis[5-(2-etil-2h-tetrazol-5-il)tetrahidro-3,4-furanodiol] como agonista a2a
GB0514809D0 (en) 2005-07-19 2005-08-24 Glaxo Group Ltd Compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2154527A1 (fr) * 1971-09-18 1973-05-11 Schering Ag

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167565A (en) * 1976-11-08 1979-09-11 Abbott Laboratories Adenosine-5'-carboxamides and method of use
US5310731A (en) * 1984-06-28 1994-05-10 Whitby Research, Inc. N-6 substituted-5'-(N-substitutedcarboxamido)adenosines as cardiac vasodilators and antihypertensive agents
US4755594A (en) * 1986-01-31 1988-07-05 Warner-Lambert Company N6 -substituted adenosines
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
WO1988003148A2 (fr) * 1986-10-31 1988-05-05 Warner-Lambert Company Derives heteroaromatiques d'adenosine
AU8276187A (en) * 1986-10-31 1988-05-25 Warner-Lambert Company Selected n6-substituted adenosines having selective a2 binding activity
EP0267878A1 (fr) * 1986-11-14 1988-05-18 Ciba-Geigy Ag Dérivés de l'adénine N9-substitués par le groupement cyclopentyle
SU1661367A1 (ru) * 1988-11-01 1991-07-07 Всесоюзный научно-исследовательский институт по креплению скважин и буровым растворам Способ гидрофобизации тампонажных материалов
SG80526A1 (en) * 1990-09-25 2001-05-22 Rhone Poulenc Rorer Int Compounds having antihypertensive and anti- ischemic properies
FR2685918B1 (fr) * 1992-01-08 1995-06-23 Union Pharma Scient Appl Nouveaux derives de l'adenosine, leurs procedes de preparation, compositions pharmaceutiques les contenant.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2154527A1 (fr) * 1971-09-18 1973-05-11 Schering Ag

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of Medicinal Chemistry, vol.16, nr.4, 1973, p.358-364. *

Also Published As

Publication number Publication date
AU3455093A (en) 1993-08-03
GEP19981357B (en) 1998-08-25
ATE153342T1 (de) 1997-06-15
RU94039545A (ru) 1997-04-27
CA2127472C (fr) 2003-11-18
AU661894B2 (en) 1995-08-10
CZ289047B6 (cs) 2001-10-17
LV11899B (lv) 1998-03-20
MD502F1 (en) 1996-03-29
HUT68095A (en) 1995-05-29
DE69219901T2 (de) 1997-11-13
JPH07502738A (ja) 1995-03-23
DK0623138T3 (da) 1997-12-15
FR2685918A1 (fr) 1993-07-09
DE69219901D1 (de) 1997-06-26
EP0623138A1 (fr) 1994-11-09
HU221304B1 (en) 2002-09-28
CA2127472A1 (fr) 1993-07-22
SK282205B6 (sk) 2001-12-03
GR3024386T3 (en) 1997-11-28
JP3224542B2 (ja) 2001-10-29
NZ246904A (en) 1995-04-27
EP0623138B1 (fr) 1997-05-21
RU2129560C1 (ru) 1999-04-27
FR2685918B1 (fr) 1995-06-23
US5229505A (en) 1993-07-20
TW254945B (fr) 1995-08-21
FI943222A0 (fi) 1994-07-06
LV11899A (lv) 1997-12-20
US5480983A (en) 1996-01-02
ES2105285T3 (es) 1997-10-16
FI943222A (fi) 1994-08-18
SK81894A3 (en) 1995-04-12
FI106205B (fi) 2000-12-15
CZ164394A3 (en) 1995-02-15
HU9402040D0 (en) 1994-09-28
UA44221C2 (uk) 2002-02-15
KR100232672B1 (ko) 1999-12-01
WO1993014102A1 (fr) 1993-07-22
EE03087B1 (et) 1998-04-15

Similar Documents

Publication Publication Date Title
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
BG103485A (en) Ketobanzamides as calpain inhibitors
MY104926A (en) Quinoline, quinazoline and cinnoline derivatives
SE9604786D0 (sv) New compounds
MY119820A (en) Guanidine mimics as factor xa inhibitors
MY113733A (en) Salts of an anti-migraine indole derivative
AU2291097A (en) Novel phenanthridines substituted in the 6 position
DK0758248T3 (da) Formuleringer til faktor IX
ATE203515T1 (de) Meta-substituierte phenylsulphonamidderivate
ZA988158B (en) Sulfinic acid derivatives and their preparation and use
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
HK1026909A1 (en) Substituted phenyl derivatives, their preparation and use
SE9504661D0 (sv) New compounds
MY115339A (en) Compositions containing micronized nebivolol
HRP930239A2 (en) Anti-inflamatory 4-aminophenol derivatives
BG103947A (en) Derivatives of 9-oxymerythromycin
EP0807633A3 (fr) (5,6)-Pyrimidin-4-ones condensées à hétéroaryle, substituées en 2,3
MD502G2 (ro) Derivaţi noi ai adenozinei, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
TR199801268T2 (xx) Ta�ikinin antagonistleri olarak 3-Azetidinilalkilpiperidinler veya pirolidinler.
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
DE69330601D1 (de) Serotoninergische ergolin derivate

Legal Events

Date Code Title Description
FG3A Granted patent for invention
IF99 Valid patent on 19990615

Free format text: EXPIRES: 20141230

MK4A Patent for invention expired